Copyright
©The Author(s) 2023.
World J Gastrointest Surg. May 27, 2023; 15(5): 871-881
Published online May 27, 2023. doi: 10.4240/wjgs.v15.i5.871
Published online May 27, 2023. doi: 10.4240/wjgs.v15.i5.871
Figure 4 Plasma cholecystokinin and peptide YY levels.
A: Plasma levels of cholecystokinin (CCK); B: Plasma levels of peptide YY (PYY). Plasma levels of CCK and PYY were measured by ELISA. aP < 0.05 compared with the TJ-43(-) group by ANOVA with Bonferroni’s post-hoc test. TJ-43: Rikkunshito; TJ-43(-): Patients without TJ-43 treatment; TJ-43(+): Patients with TJ-43 treatment; CCK: Cholecystokinin; PYY: Peptide YY; POD: Postoperative day.
- Citation: Kono H, Hosomura N, Amemiya H, Shoda K, Furuya S, Akaike H, Kawaguchi Y, Kawaida H, Ichikawa D. Rikkunshito increases appetite by enhancing gastrointestinal and incretin hormone levels in patients who underwent pylorus-preserving pancreaticoduodenectomy: A retrospective study. World J Gastrointest Surg 2023; 15(5): 871-881
- URL: https://www.wjgnet.com/1948-9366/full/v15/i5/871.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i5.871